Single-dose adaptogen of the oestrogen-activity type. Pre-clinical only. no clinical trial record in the corpus.
mechanism confidence: low
Structural analogue of bromantane: N-(2-adamantyl)-N-(p-chlorobenzoyl)amine. Distinguished from bromantane by a more uniform two-compartment pharmacokinetic profile (fast-equilibrating tissues include kidneys, lungs and skeletal muscle. i.e. the third tier collapses into the first tier). The pharmacology literature is sparse: only the original Khoronko 2005 pharmacokinetic study and a Vernigora 2024 paper on structural analogues. Chlodantane is rarely the focus of a paper. most actoprotector research has shifted to bromantane and the camphor-derived N-(camphan-2-yl)anilines. The compound sits in a methodological shadow of its better-studied sibling.
- Pharmacokinetics in rats (Khoronko 2005): two-compartment tissue distribution. fast equilibration includes brain, liver, spleen, testes, kidneys, lungs, skeletal muscle; only fat shows slow equilibration. Contrast with bromantane (3 compartments).
- Vernigora 2024 camphor-derived analogues show anxiolytic activity in NOR and extrapolation tests; lead compound 4e. structural class overlaps with chlodantane scaffold
- Original programme: Stdentsov 2013 review (212 refs) on adaptogens, immunomodulators, actoprotectors, antihypoxants, antioxidants, radioprotectors. chlodantane grouped with the actoprotector class but with limited dedicated pharmacology
grade: Sparse. Most actoprotector literature focuses on bemitil and bromantane. Chlodantane-specific papers on CyberLeninka are dominated by the pharmacokinetics comparison. Mechanism extrapolation is from the structural class (adamantane derivatives).
- Why is chlodantane pharmacokinetically more uniform than bromantane? The p-chlorobenzoyl vs p-bromophenyl substitution changes the lipophilicity profile
- Almost no mechanism-specific studies. should sit in an adjacent class with thinner characterisation in our map
- Comparative efficacy vs bromantane. never directly tested in head-to-head swimming assays
- PMID 200953992009[Meteoadaptogenic properties of antihypoxic drugs].Eksperimental'naia i klinicheskaia farmakologiia
- PMID 183181952007[Meteoadaptogenic properties of peptide drugs in healthy volunteers].Eksperimental'naia i klinicheskaia farmakologiia
- PMID 164636292005[Community pneumonia in recruits: the algorithm of complex two-staged rehabilitation treatment].Voenno-meditsinskii zhurnal
- PMID 127107182003Effects of the 2-ethylthiobenzimidazole hydrobromide (bemithyl) on carbohydrate metabolism in cirrhotic rat liver. doi:10.1078/0940-2993-00270Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie
- PMID 119874232002[Correction of physical performance of mice with the derivatives of 3-oxypyridine and pyridine].Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine
- PMID 108190472000[Experimental study of combined effect of actoprotectors and radioprotectors in radiation injury].Radiatsionnaia biologiia, radioecologiia
- PMID 109345942000[Effect of the long term administration of bromantan on the reproductive function in rats].Eksperimental'naia i klinicheskaia farmakologiia
- PMID 95423351998[Changes in the serum albumin system during toxic syndrome and their pharmacologic correction].Izvestiia Akademii nauk. Seriia biologicheskaia
- PMID 16501061991[Differentiated psychopharmacotherapy of anergic conditions and the search for predictors of its effectiveness].Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)
- PMID 30669831988[Effect of actoprotectors on the work capacity of operators during modeling of various factors of space flight].Kosmicheskaia biologiia i aviakosmicheskaia meditsina
14 total in corpus · top 10 shown
Reviewed against the archive corpora on 2026-09-16. Source-grounded. No clinical claims. Synthesis prose may preserve published experimental context from papers; that is research history, not a recommendation.